FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2291897574> ?p ?o ?g. }

• W2291897574 endingPage "20067" @default.
• W2291897574 startingPage "20054" @default.
• W2291897574 abstract "// Bing Z. Carter 1 , Po Yee Mak 1 , Ye Chen 1 , Duncan H. Mak 1 , Hong Mu 1 , Rodrigo Jacamo 1 , Vivian Ruvolo 1 , Stefan T. Arold 2 , John E. Ladbury 3 , Jared K. Burks 1 , Steven Kornblau 1 , Michael Andreeff 1 1 Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2 King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center, Division of Biological and Environmental Sciences and Engineering, Thuwal, Saudi Arabia 3 Department of Biochemistry and Molecular Biology and Center for Biomolecular Structure and Function, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Correspondence to: Bing Z. Carter, e-mail: bicarter@mdanderson.org Michael Andreeff, e-mail: mandreef@mdanderson.org Keywords: AML, ARC, NFκB, chemoresistance Received: January 08, 2016      Accepted: February 15, 2016      Published: March 04, 2016 ABSTRACT To better understand how the apoptosis repressor with caspase recruitment domain (ARC) protein confers drug resistance in acute myeloid leukemia (AML), we investigated the role of ARC in regulating leukemia-mesenchymal stromal cell (MSC) interactions. In addition to the previously reported effect on AML apoptosis, we have demonstrated that ARC enhances migration and adhesion of leukemia cells to MSCs both in vitro and in a novel human extramedullary bone/bone marrow mouse model. Mechanistic studies revealed that ARC induces IL1β expression in AML cells and increases CCL2, CCL4, and CXCL12 expression in MSCs, both through ARC-mediated activation of NFκB. Expression of these chemokines in MSCs increased by AML cells in an ARC/IL1β-dependent manner; likewise, IL1β expression was elevated when leukemia cells were co-cultured with MSCs. Further, cells from AML patients expressed the receptors for and migrated toward CCL2, CCL4, and CXCL12. Inhibition of IL1β suppressed AML cell migration and sensitized the cells co-cultured with MSCs to chemotherapy. Our results suggest the existence of a complex ARC-regulated circuit that maintains intimate connection of AML with the tumor microenvironment through NFκB/IL1β-regulated chemokine receptor/ligand axes and reciprocal crosstalk resulting in cytoprotection. The data implicate ARC as a promising drug target to potentially sensitize AML cells to chemotherapy." @default.
• W2291897574 created "2016-06-24" @default.
• W2291897574 creator A5001035782 @default.
• W2291897574 creator A5008665039 @default.
• W2291897574 creator A5009423275 @default.
• W2291897574 creator A5016607292 @default.
• W2291897574 creator A5026060144 @default.
• W2291897574 creator A5034434552 @default.
• W2291897574 creator A5036067544 @default.
• W2291897574 creator A5051843836 @default.
• W2291897574 creator A5057051999 @default.
• W2291897574 creator A5067312104 @default.
• W2291897574 creator A5075486072 @default.
• W2291897574 creator A5079262854 @default.
• W2291897574 date "2016-03-04" @default.
• W2291897574 modified "2023-10-17" @default.
• W2291897574 title "Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network" @default.
• W2291897574 cites W1622378427 @default.
• W2291897574 cites W1927732700 @default.
• W2291897574 cites W1937502920 @default.
• W2291897574 cites W1966976790 @default.
• W2291897574 cites W1979421565 @default.
• W2291897574 cites W1980521997 @default.
• W2291897574 cites W1982729887 @default.
• W2291897574 cites W1985190362 @default.
• W2291897574 cites W1987180287 @default.
• W2291897574 cites W1988356885 @default.
• W2291897574 cites W1992852732 @default.
• W2291897574 cites W2000980282 @default.
• W2291897574 cites W2002039365 @default.
• W2291897574 cites W2006028950 @default.
• W2291897574 cites W2025154850 @default.
• W2291897574 cites W2027364921 @default.
• W2291897574 cites W2035614371 @default.
• W2291897574 cites W2038711738 @default.
• W2291897574 cites W2043046186 @default.
• W2291897574 cites W2045321300 @default.
• W2291897574 cites W2045476203 @default.
• W2291897574 cites W2053737668 @default.
• W2291897574 cites W2058170491 @default.
• W2291897574 cites W2065544737 @default.
• W2291897574 cites W2070479140 @default.
• W2291897574 cites W2074711837 @default.
• W2291897574 cites W2081247459 @default.
• W2291897574 cites W2082826369 @default.
• W2291897574 cites W2087754901 @default.
• W2291897574 cites W2091552147 @default.
• W2291897574 cites W2094442466 @default.
• W2291897574 cites W2096176750 @default.
• W2291897574 cites W2096829343 @default.
• W2291897574 cites W2097625578 @default.
• W2291897574 cites W2103133890 @default.
• W2291897574 cites W2105241495 @default.
• W2291897574 cites W2112666278 @default.
• W2291897574 cites W2117954220 @default.
• W2291897574 cites W2127056481 @default.
• W2291897574 cites W2127362505 @default.
• W2291897574 cites W2136650003 @default.
• W2291897574 cites W2137984061 @default.
• W2291897574 cites W2144138595 @default.
• W2291897574 cites W2147907541 @default.
• W2291897574 cites W2162995424 @default.
• W2291897574 cites W2999065750 @default.
• W2291897574 cites W4235107153 @default.
• W2291897574 cites W4379365691 @default.
• W2291897574 cites W620649595 @default.
• W2291897574 doi "https://doi.org/10.18632/oncotarget.7911" @default.
• W2291897574 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4991438" @default.
• W2291897574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26956049" @default.
• W2291897574 hasPublicationYear "2016" @default.
• W2291897574 type Work @default.
• W2291897574 sameAs 2291897574 @default.
• W2291897574 citedByCount "30" @default.
• W2291897574 countsByYear W22918975742017 @default.
• W2291897574 countsByYear W22918975742018 @default.
• W2291897574 countsByYear W22918975742019 @default.
• W2291897574 countsByYear W22918975742020 @default.
• W2291897574 countsByYear W22918975742021 @default.
• W2291897574 countsByYear W22918975742022 @default.
• W2291897574 countsByYear W22918975742023 @default.
• W2291897574 crossrefType "journal-article" @default.
• W2291897574 hasAuthorship W2291897574A5001035782 @default.
• W2291897574 hasAuthorship W2291897574A5008665039 @default.
• W2291897574 hasAuthorship W2291897574A5009423275 @default.
• W2291897574 hasAuthorship W2291897574A5016607292 @default.
• W2291897574 hasAuthorship W2291897574A5026060144 @default.
• W2291897574 hasAuthorship W2291897574A5034434552 @default.
• W2291897574 hasAuthorship W2291897574A5036067544 @default.
• W2291897574 hasAuthorship W2291897574A5051843836 @default.
• W2291897574 hasAuthorship W2291897574A5057051999 @default.
• W2291897574 hasAuthorship W2291897574A5067312104 @default.
• W2291897574 hasAuthorship W2291897574A5075486072 @default.
• W2291897574 hasAuthorship W2291897574A5079262854 @default.
• W2291897574 hasBestOaLocation W22918975741 @default.
• W2291897574 hasConcept C121608353 @default.
• W2291897574 hasConcept C126322002 @default.
• W2291897574 hasConcept C185592680 @default.
• W2291897574 hasConcept C190283241 @default.

• next